MAPT and Cognitive impairment: The astrocytic signaling protein IGFBP2 is increased in AD,67 associated with clinical diagnosis of mild cognitive impairment or dementia, AD‐like brain atrophy, and CSF tau levels,68, 69 supporting our finding of significantly increased blood levels in sDS.